149157-45-9

Upstream product

• 141423-25-8 <<3-(2R,4S,5S,6R,8E),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-9-phenyl-8-nonenyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 149157-44-8 <3(2R,3R,4S,5S,6R,8E),4R>-3-(3,5-dihydroxy-2,4,6-trimethyl-1-oxo-9-phenyl-8-nonenyl)-4-(phenylmethyl)-2-oxazolidinone 

Downstream Products

• 152567-31-2 (3R,4S,5R,6S,7S)-4-(tert-Butyl-dimethyl-silanyloxy)-8-hydroxy-6-(4-methoxy-benzyloxy)-3,5,7-trimethyl-octanal 
• 149157-49-3 <2S,3S,4R,5S,6R,8E>-9-iodo-2,4,6-trimethyl-3-((4-methoxyphenyl)methoxy)-5-((1,1-dimethylethyl)dimethylsiloxy)-1-non-8-enol 
• 149157-58-4 1,1-dimethylethyl<2E,4S,5R,6S,8R,9S,10S,11S,12R,13S,14R,16E>-9-hydroxy-17-iodo-4,6,8,10,12,14-hexamethyl-7-oxo-11-((4-methoxyphenyl)methoxy)-5,13-bis((1,1-dimethylethyl)dimethylsiloxy)heptadeca-2,16-dienoate 
• 149157-59-5 1,1-dimethylethyl<2E,4S,5R,6S,8R,9S,10R,11R,12R,13S,14R,16E>-17-iodo-4,6,8,10,12,14-hexamethyl-7-oxo-11-((4-methoxyphenyl)methoxy)-5,9,13-tris((1,1-dimethylethyl)dimethylsiloxy)heptadeca-2,16-dienoate 
• 149157-47-1 <2S,4S,4(1R,2S,3R,5E),5S>-2-(4-methoxyphenyl)-5-methyl-4-(1,3-dimethyl-6-phenyl-2-((1,1-dimethylethyl)dimethylsiloxy)-5-hexenyl)-1,3-dioxane 
• 149157-48-2 <2S,3S,4R,5S,6R,8E>-2,4,6-trimethyl-9-phenyl-5-((1,1-dimethylethyl)dimethylsiloxy)-3-((4-methoxyphenyl)methoxy)-1-non-8-enol 
• 149157-50-6 <2R,3R,4R,5S,6R,8E>-9-iodo-2,4,6-trimethyl-5-((1,1-dimethylethyl)dimethylsiloxy)-3-((4-methoxyphenyl)methoxy)-8-nonenal 
• 92308-96-8 rutamycin B 
• 149157-46-0 <2S,4S,4(1R,2S,3R,5E),5S>-2-(4-methoxyphenyl)-5-methyl-4-(2-hydroxy-1,3-dimethyl-6-phenyl-5-hexenyl)-1,3-dioxane 

Relevant academic research and scientific papers

Studies directed toward the synthesis of the rutamycins. Assemblage of the polypropionate region of rutamycin B

The asymmetric synthesis of the polypropionate segment of rutamycin B is reported. In this convergent synthesis the construction of the C1-C8 and C9-C17 subunits and their union through a double stereodifferenti

Total synthesis of the macrolide antibiotic rutamycin B

A convergent asymmetric synthesis of the macrolide antibiotic rutamycin B has been achieved through the synthesis and coupling of its spiroketal and polypropionate subunits. Both fragments were constructed utilizing auxiliary based asymmetric aldol and al